Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Umeclidinium and Vilanterol Alone and in Combination: A Randomized Crossover Trial

Umeclidinium bromide (GSK573719; UMEC), a new long-acting muscarinic receptor antagonist (LAMA), is in development with vilanterol (GW642444; VI), a selective long-acting β(2) agonist (LABA), as a once-daily inhaled combination therapy for the treatment of chronic obstructive pulmonary disease (COPD...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelleher, Dennis L., Mehta, Rashmi S., Jean-Francois, Bernadette M., Preece, Andrew F., Blowers, James, Crater, Glenn D., Thomas, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524248/
https://www.ncbi.nlm.nih.gov/pubmed/23284643
http://dx.doi.org/10.1371/journal.pone.0050716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524248/
https://www.ncbi.nlm.nih.gov/pubmed/23284643
http://dx.doi.org/10.1371/journal.pone.0050716

Ejemplares similares